Trump to unveil new drug price deal with Regeneron amid affordability push
Regeneron would be the 17th drug company to agree to lower its prices as part of the administration’s Most Favored Nation initiative.
Last updated: 2026-04-24 17:44:42 ET
Regeneron would be the 17th drug company to agree to lower its prices as part of the administration’s Most Favored Nation initiative.
Timbercraft owner Doug Schroeder has a new strategy to help the niche dwellings go mainstream.
As Democrats try to find a way back to power in Washington, some see tax cuts as a quick and easy way to address affordability. The wonks are freaking...
Doormen and building owners reached a deal late Friday, avoiding a strike but showing how the affordability crunch is squeezing nearly everyone who li...
Unlock the AI Macro Analyst to drill down into the data, explore hidden risks, and query the entire market briefing in real-time.
LOG IN / SUBSCRIBE